Reading time: 5 minutes Dolores Mruk, PhD Cancer treatments have come a long way since the early 1900s, evolving from chemotherapy and radiotherapy to more targeted interventions. One promising approach involves the use of bispecific antibodies (bsAbs)—engineered molecules that help in fighting cancer. Today, these immunotherapies are being studied across different malignancies, with a particular... Continue Reading →